Target intelligence / Profile preview

Urea and Ammonia

Molecular classification
Other (nitrogenous waste/metabolite), Other (nitrogenous waste/metabolite, weak base)
01

Overview

Urea and ammonia are nitrogen-containing metabolites involved in the body's disposal of excess nitrogen. Ammonia is produced during amino acid catabolism and is extremely toxic, particularly to neurons. The liver converts ammonia into urea via the urea cycle—a series of enzymatic reactions that make ammonia safe for excretion. Urea is then released into the bloodstream and excreted primarily via the kidneys. Both molecules play central roles in nitrogen excretion, osmotic regulation, and acid-base homeostasis. Disruption of urea or ammonia metabolism leads to metabolic and neurological diseases, such as urea cycle disorders, hepatic encephalopathy, and acute or chronic kidney failure[1][3][4][5][6][2][8]. Key context: - These are metabolic intermediates, not molecular targets (receptor, enzyme, transporter, etc.). - Disease-modifying strategies target enzymes or transporters of these pathways, not urea or ammonia themselves. - Ammonia accumulation is directly toxic; urea accumulation is mostly a marker, not a toxin per se[5][6]. - Drugs may target the pathways or processes that regulate their metabolism or excretion[4]. "Urea and Ammonia" as a combined molecular target entry is incorrect; correct targets would be individual components of the urea cycle or ammonia metabolism pathways.

Other names
CarbamideAzaneNH3
02

Mechanism of action

Promoting alternative nitrogen excretion pathways (through scavenger drugs)[4] Enhancing conversion or removal of ammonia (e.g., by gut acidification or bacterial modulation)

03

Biological functions

Detoxification (via urea cycle)Nitrogen excretionAcid-base homeostasis (ammonia, especially in kidneys[5][6])Osmoregulation (urea, in kidney medullary concentration[5][6])
04

Disease associations

Urea cycle disorders (inborn errors of metabolism)Hepatic encephalopathy (ammonia toxicity in liver failure)[3][5][4]Kidney disease (urea/ammonia handling[5])Cancer metabolic adaptations ("urea cycle" can impact cancer cell proliferation[2][8])
05

Safety considerations

Ammonia is highly neurotoxic if it accumulates (encephalopathy, coma)[3][4][5]Urea is less toxic, but high levels can indicate kidney dysfunction (uremia)[5][6]
06

Interacting drugs

Sodium benzoate (ammonia scavenger, in urea cycle disorders)[4]

4 more in the full profile.

07

Biomarkers

Serum ammonia (for liver dysfunction and urea cycle disorders)[3][4][5]Serum urea (Blood Urea Nitrogen, for kidney function)[5][6]

Beyond the preview

Go deeper on Urea and Ammonia.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Urea and Ammonia.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call